Cargando…

Convalescent plasma from people vaccinated after COVID-19 infection

Detalles Bibliográficos
Autores principales:	Jabal, Kamal Abu, Wiegler, Karine Beiruti, Edelstein, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987300/ https://www.ncbi.nlm.nih.gov/pubmed/33778791 http://dx.doi.org/10.1016/S2666-5247(21)00060-4

Ejemplares similares

Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel
por: Kuodi, Paul, et al.
Publicado: (2022)

SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January–March 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021)

Association between BNT162b2 vaccination and health-related quality of life up to 18 months post-SARS-CoV-2 infection in Israel
por: Kuodi, Paul, et al.
Publicado: (2023)

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
por: Abu Jabal, Kamal, et al.
Publicado: (2021)

Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020–October 2021
por: Edelstein, Michael, et al.
Publicado: (2022)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Convalescent plasma in patients hospitalised with COVID-19
por: Liu, Sean T H, et al.
Publicado: (2021)

Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Using SARS-CoV-2 anti-S IgG levels as a marker of previous infection: example from an Israeli healthcare worker cohort.
por: Abu Jabal, Kamal, et al.
Publicado: (2022)

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19
por: So-Osman, Cynthia, et al.
Publicado: (2022)

COVID-19 vaccines: addressing hesitancy in young people with allergies
por: Abrams, Elissa M, et al.
Publicado: (2021)

COVID-19 vaccine effectiveness in people with substance use disorder
por: Huang, Yueqin
Publicado: (2023)

Waning effectiveness of COVID-19 vaccines
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Assessing the effectiveness of COVID-19 vaccines in older people in Latin America
por: Rodriguez-Morales, Alfonso J, et al.
Publicado: (2022)

The elusive goal of COVID-19 vaccine immunity
por: Abu-Raddad, Laith J, et al.
Publicado: (2023)

Comparison of Doppler Ultrasound and Computerized Tomographic Angiography in Evaluation of Cervical Arteries Stenosis in Stroke Patients, a Retrospective Single-Center Study
por: Simaan, Naaem, et al.
Publicado: (2023)

Characteristics of Multiple Acute Concomitant Cerebral Infarcts Involving Different Arterial Territories
por: Simaan, Naaem, et al.
Publicado: (2023)

Lessons about COVID-19 vaccine hesitancy among minority ethnic people in the UK
por: Kadambari, Seilesh, et al.
Publicado: (2021)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Flare of rheumatoid arthritis after COVID-19 vaccination
por: Terracina, Katherine A, et al.
Publicado: (2021)

Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented
por: Ryan, Margaret, et al.
Publicado: (2022)

A look-back at convalescent plasma to treat COVID-19
por: Garraud, Olivier, et al.
Publicado: (2021)

COVID-19 in people with HIV
por: Xu, Zhe, et al.
Publicado: (2020)

The antibody response of haematological malignancies to COVID-19 infection and vaccination
por: Seebacher, Nicole A.
Publicado: (2022)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Suspending methotrexate for 2 weeks after COVID-19 vaccination
por: Coates, Laura C, et al.
Publicado: (2022)

Blood lipids after COVID-19 infection
por: Durrington, Paul
Publicado: (2023)

Current Perspectives of convalescent plasma therapy in COVID-19
por: Sahu, Kamal Kant, et al.
Publicado: (2020)

Providing COVID-19 vaccination to refugees and displaced people: lessons from the vaccine roll-out for the Rohingya refugees in Cox's Bazaar, Bangladesh
por: Alam, Ali M.
Publicado: (2022)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

COVID-19 in children and young people
por: Felsenstein, Susanna, et al.
Publicado: (2020)

COVID-19 immunisation in older people
por: Vigezzi, Giacomo Pietro, et al.
Publicado: (2022)

Interplay of infection and vaccination in long-term protection from COVID-19
por: Tan, Hyon-Xhi, et al.
Publicado: (2022)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

Developing COVID-19 vaccine policy in increments
por: Saag, Michael S
Publicado: (2021)

The Management of Convalescence
Publicado: (1907)

Hospital admissions due to COVID-19 in Scotland after one dose of vaccine
por: Dean, Natalie
Publicado: (2021)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

Adult-onset Still's disease after mRNA COVID-19 vaccine
por: Magliulo, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i4pmn4uu9b9241llao0numrjn3